Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Yang, Boyu [1 ]
Wu, Shaowen [1 ]
Yu, Shanshan [1 ]
Liang, Xiaoling [1 ]
Liu, Qifa [2 ]
Huang, Fen [2 ]
Liang, Lingyi [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangdong Prov Clin Res Ctr Ocular Dis,State Key, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Guangzhou, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
BONE-MARROW-TRANSPLANTATION; VISUAL-EVOKED POTENTIALS; VERSUS-HOST-DISEASE; CYTOMEGALOVIRUS RETINITIS; OCULAR FINDINGS; SOLID-ORGAN; EYE;
D O I
10.1038/s41433-022-02250-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To study the posterior segment complications (PSC) and the risk factors in patients after allogeneic hematopoietic stem cell transplantation (HSCT). Methods This cross-sectional, case-control study enroled 143 patients who received allogeneic HSCT. Comprehensive ocular examinations were performed to evaluate PSC and ocular Graft-versus-Host Disease (oGVHD). PSC was diagnosed based on the characteristic fundus findings and auxiliary examinations. Visual-evoked potential was examined in patients with unexplained visual loss and suspected visual pathway pathology (VPP). Ocular surface disease index, corneal fluorescein staining, conjunctival injection and Schirmer's test were scored to diagnose oGVHD. Results PSC was detected in 36 (25.2%) patients, while 107 (74.8%) patients were not. Among them, 102 (71.3%) patients were diagnosed with oGVHD. The most common PSC included cytomegalovirus retinitis (13/143, 9.1%) and VPP (7/143, 4.9%). Central nervous system relapse of leukaemia was detected in four out of seven cases of VPP. Patients with PSC had worse visual acuity, lower prevalence and milder severity of oGVHD, and more donors from unrelated and human leucocyte antigen (HLA)-mismatch (all P < 0.05). PSC was associated with transplant from unrelated (OR = 6.494, 95% CI: 1.635-25.794, P = 0.008) and HLA-mismatched (OR = 7.193, 95% CI: 2.829-18.291, P < 0.001) donor but not with the occurrence of systemic GVHD or oGVHD. Conclusions PSC in post-HSCT patients was more common than previously noted, deserving the concern of ophthalmologists, especially in patients with unrelated or HLA-mismatched donors.
引用
收藏
页码:1816 / 1821
页数:6
相关论文
共 50 条
  • [21] Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
    Shen, Biao
    Ma, Yueshen
    Zhang, Haixiao
    Wang, Mingyang
    Liu, Jia
    Cao, Jiaxin
    Guo, Wenwen
    Feng, Dan
    Yang, Donglin
    Zhang, Rongli
    Chen, Xin
    Ma, Qiaoling
    Zhai, Weihua
    Feng, Sizhou
    Han, Mingzhe
    Pang, Aiming
    Jiang, Erlie
    BLOOD SCIENCE, 2022, 4 (02): : 83 - 88
  • [22] INVESTIGATION OF THE FREQUENCY AND RISK FACTORS OF CARDIAC COMPLICATIONS AFTER INITIAL ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Yanagisawa, Ryu
    Nakazawa, Hideyuki
    Harada, Mikiko
    Sakai, Hitoshi
    Nishina, Sayaka
    Kawakami, Toru
    Kawakami, Fumihiro
    Fujiwara, Shin-ichiro
    Motoki, Hirohiko
    Ito, Toshiro
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 535 - 535
  • [23] Incidence and Risk Factors of Acute Cardiovascular Complications After Hematopoietic Stem Cell Transplantation
    Vasbinder, Alexi
    Anderson, Elizabeth
    Catalan, Tonimarie
    Chu, Catherine
    Kotzin, Megan
    Azam, Tariq
    Perry, Daniel
    Shadid, Husam
    Rochlen, Matthew
    Yentz, Sarah
    Schneider, Bryan
    Leja, Monika
    Lao, Christopher
    Fecher, Leslie
    Nathan, Sunita
    Okwuosa, Tochi
    Hayek, Salim
    CIRCULATION, 2022, 146
  • [24] Allogeneic hematopoietic stem cell transplantation - Complications and results
    Tabbara, IA
    Zimmerman, K
    Morgan, C
    Nahleh, Z
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (14) : 1558 - 1566
  • [25] Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea
    J-H Yoo
    D-G Lee
    S M Choi
    J-H Choi
    Y-H Park
    Y-J Kim
    H-J Kim
    S Lee
    D-W Kim
    J-W Lee
    W-S Min
    W-S Shin
    C-C Kim
    Bone Marrow Transplantation, 2004, 34 : 497 - 504
  • [26] Severe neurological complications after allogeneic hematopoietic stem cell transplantation in children
    Wojcik, D
    Slociak, M
    Toporski, J
    Katwak, K
    Gorczynska, E
    Turkiewicz, D
    Ussowick, M
    Chybrcka, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S103 - S103
  • [27] Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea
    Yoo, JH
    Lee, DG
    Choi, SM
    Choi, JH
    Park, YH
    Kim, YJ
    Kim, HJ
    Lee, S
    Kim, DW
    Lee, JW
    Min, WS
    Shin, WS
    Kim, CC
    BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 497 - 504
  • [28] Central nervous system complications after allogeneic hematopoietic stem cell transplantation
    Chaudhary, Ranjit Kumar
    Dhakal, Prajwal
    Aryal, Aashrayata
    Bhatt, Vijaya Raj
    FUTURE ONCOLOGY, 2017, 13 (25) : 2297 - 2312
  • [29] Late-onset noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation- risk factors, prognosis
    Isik, O.
    Seval, G. Cengiz
    Erol, S.
    Toprak, S. K.
    Kumbasar, O. Ozdemir
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [30] Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
    Fazekas, Tamas
    Attarbaschi, Andishe
    Lawitschka, Anita
    Seidel, Markus
    Poetschger, Ulrike
    Peters, Christina
    Mann, Georg
    Gadner, Helmut
    Matthes-Martin, Susanne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 115 - 119